loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Gadoteridol in Europe. Original Data : EMA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5BRACCO IMAGING ITALIA Srl

02 4Bracco International B.V.

03 1Bracco International BV,

04 6Bracco Suisse SA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : ProHance

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 279.3 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : Prohance

Dosage Form : Gadoteridol 1.396,5Mg 5Ml 1 Units Parenteral Use

Dosage Strength : 1 ampoule EV 5 ml 279,3 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : Prohance

Dosage Form : Gadoteridol 13.965Mg 50Ml 1 Units Parenteral Use

Dosage Strength : 1 bottle EV 50 ml 279,3 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : Prohance

Dosage Form : Gadoteridol 2.793Mg 10Ml 1 Units Parenteral Use

Dosage Strength : 1 ampoule EV 10 ml 279,3 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : Prohance

Dosage Form : Gadoteridol 4.189,5Mg 15Ml 1 Units Parenteral Use

Dosage Strength : 1 ampoule EV 15 ml 279,3 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : Prohance

Dosage Form : Gadoteridol 5.586Mg 20Ml 1 Units Parenteral Use

Dosage Strength : 1 ampoule EV 20 ml 279,3 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : ProHance

Dosage Form : Injection fluid, resolution

Dosage Strength : 279,3 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : ProHance

Dosage Form : Injection fluid, resolution

Dosage Strength : 279,3 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : ProHance

Dosage Form : Injection fluid, resolution

Dosage Strength : 279,3 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Gadoteridol

Brand Name : ProHance

Dosage Form : Injection fluid, resolution

Dosage Strength : 279,3 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank